Marvin A. Chirelstein Colloquium.
Open to the Yale Community.
Lunch will be available.
Ron Creamer is a seasoned tax practitioner in all types of acquisitions and dispositions, particularly cross-border transactions. Mr. Creamer is noted for his calm, business-oriented approach and his ability to achieve consensus in complex negotiations. In addition to advising on the tax aspects of M&A transactions, Mr. Creamer regularly counsels clients on the execution and IRS review of tax-efficient financing techniques and capital markets strategies. Notable transactions include representing:
UScellular’s independent directors in the pending $4.4 billion sale of UScellular’s wireless operations and select spectrum assets to T‑Mobile;
Deutsche Börse in its €3.9 billion acquisition of SimCorp and the combination of ISS and Qontigo’s index business as ISS STOXX;
Credit Suisse in its CHF3.475 billion merger into UBS;
Jefferies in the expansion of its strategic alliance with Sumitomo Mitsui Banking Corporation, which includes a total commitment of up to $3.4 billion to Jefferies by SMBC;
Texas Capital Bank in the $3.4 billion sale of BankDirect to Truist;
ADT in the $1.6 billion sale of its commercial business to GTCR and its $1.2 billion equity investment from State Farm;
Convey Health Solutions in its $1.1 billion take-private acquisition by TPG Capital;
Lifezone Metals in its approximately $1 billion SPAC combination with GoGreen Investments;
Hasbro in the $500 million sale of its eOne Film and TV Business to Lionsgate;
WiseTech Global in its $414 million acquisition of Blume Global from funds managed by Apollo and EQT and its $230 million acquisition of Envase Technologies from Firmament;
Ahold Delhaize in the sale of its FreshDirect business to Getir;
Airspan in the sale of Mimosa to Radisys;
entrotech in the formation of PPG Advanced Surface Technologies, a joint venture with PPG Industries;
Illumina in its spin-off of GRAIL;
OMERS Private Equity in its acquisition of a majority stake in Knight Commercial;
Owl Rock in its investment in Amergin Asset Management;
RedHill Biopharma in its agreement with HealthCare Royalty to extinguish its debt obligations in exchange for Movantik;
Taro in its acquisition of Alchemee, formerly The Proactiv Company, from Galderma; and
Thrivent in its acquisition of a majority stake in College Avenue.
Mr. Creamer has been repeatedly recognized as one of the country’s leading tax practitioners by, among others, Chambers Global, Chambers USA, Law360, The Legal 500 US and The Legal 500 UK, The Best Lawyers in America and Lawdragon.
Mr. Creamer was born in Baltimore, Maryland. He received an A.B. from Princeton University in 1987, a J.D. from Yale Law School in 1991 and an M.P.P.M. from Yale University in 1991.
Co-sponsored with the Yale Law & Business Society and the Chae Initiative in Private Sector Leadership.